1388. Transanal vs Laparoscopic Total Mesorectal Excision and 3-Year Disease-Free Survival in Rectal Cancer: The TaLaR Randomized Clinical Trial.
作者: Ziwei Zeng.;Shuangling Luo.;Hong Zhang.;Miao Wu.;Dan Ma.;Quan Wang.;Ming Xie.;Qing Xu.;Jun Ouyang.;Yi Xiao.;Yongchun Song.;Bo Feng.;Qingwen Xu.;Yanan Wang.;Yi Zhang.;Lishuo Shi.;Li Ling.;Xingwei Zhang.;Liang Huang.;Zuli Yang.;Junsheng Peng.;Xiaojian Wu.;Donglin Ren.;Meijin Huang.;Ping Lan.;Jianping Wang.;Weidong Tong.;Mingyang Ren.;Huashan Liu.;Liang Kang.; .
来源: JAMA. 2025年333卷9期774-783页
Previous studies have demonstrated the advantages of short-term histopathological outcomes and complications associated with transanal total mesorectal excision (TME) compared with laparoscopic TME. However, the long-term oncological outcomes of transanal TME remain ambiguous. This study aims to compare 3-year disease-free survival of transanal TME with laparoscopic TME.
1399. Polygenic Risk Score Added to Conventional Case Finding to Identify Undiagnosed Chronic Obstructive Pulmonary Disease.
作者: Jingzhou Zhang.;Brian D Hobbs.;Edwin K Silverman.;David Sparrow.;Victor E Ortega.;Hanfei Xu.;Chengyue Zhang.;Josée Dupuis.;Allan J Walkey.;George T O'Connor.;Michael H Cho.;Matthew Moll.
来源: JAMA. 2025年333卷9期784-792页
Chronic obstructive pulmonary disease (COPD) is often undiagnosed. Although genetic risk plays a significant role in COPD susceptibility, its utility in guiding spirometry testing and identifying undiagnosed cases is unclear.
|